-
1.Quinone derivatives, method and use of preparing same, and pharmaceutical composition 失效
标题翻译: 喹诺酮衍生物,其制备方法和用途以及药物组合物公开(公告)号:EP0163317B1
公开(公告)日:1988-08-24
申请号:EP85106732.2
申请日:1985-05-31
申请人: Eisai Co., Ltd. , NAGOYA UNIVERSITY
发明人: Ozawa, Takayuki , Nishikimi, Morimitsu , Suzuki, Hiroshi , Shimomura, Yoshiharu , Yamatsu, Isao , Abe, Shinya , Yamada, Hiroshi , Fujimori, Tohru , Takamura, Tadanobu
IPC分类号: C07C59/90 , C07C59/64 , C07C51/347 , A61K31/19
CPC分类号: C07C59/90 , C07C51/16 , C07C51/347 , Y10S514/822 , Y10S514/824 , Y10S514/87 , C07C59/64
-
2.Quinone derivatives, method and use of preparing same, and pharmaceutical composition 失效
标题翻译: 醌衍生物,它们的制备方法,它们的用途和药物组合物。公开(公告)号:EP0163317A1
公开(公告)日:1985-12-04
申请号:EP85106732.2
申请日:1985-05-31
申请人: Eisai Co., Ltd. , NAGOYA UNIVERSITY
发明人: Ozawa, Takayuki , Nishikimi, Morimitsu , Suzuki, Hiroshi , Shimomura, Yoshiharu , Yamatsu, Isao , Abe, Shinya , Yamada, Hiroshi , Fujimori, Tohru , Takamura, Tadanobu
IPC分类号: C07C59/90 , C07C59/64 , C07C51/347 , A61K31/19
CPC分类号: C07C59/90 , C07C51/16 , C07C51/347 , Y10S514/822 , Y10S514/824 , Y10S514/87 , C07C59/64
摘要: A quinone derivative of the formula (I):
in which A is a group of the formula: (IV):
or a group of the formula (V):
in which X and Y are either the same as or different from each other and each are hydroxy, methoxy or hydrogen; and n is an integer of 1 to 5, and methods of preparing such derivative are disclosed. The compounds exhibit useful pharmacological properties which make them useful in pharmaceutical compositions.-
公开(公告)号:EP0645391B1
公开(公告)日:2001-11-21
申请号:EP94111783.0
申请日:1994-07-28
申请人: Eisai Co., Ltd.
发明人: Miyazawa, Shuhei , Hoshino, Yorihisa , Shibata, Hisashi , Hirota, Kazuo , Kameyama, Takaaki , Abe, Shinya , Yamanaka, Takashi
IPC分类号: C07D498/08 , C07D451/14 , C07D471/08 , C07D211/58 , C07D451/04 , C07D221/24 , C07D207/14 , C07D491/08 , C07D451/02 , C07D471/18 , A61K31/46
CPC分类号: C07D451/02 , C07D207/14 , C07D211/58 , C07D221/24 , C07D451/04 , C07D451/14 , C07D471/08 , C07D491/08 , C07D498/08
-
公开(公告)号:EP0353474B1
公开(公告)日:1995-04-05
申请号:EP89112204.6
申请日:1989-07-04
申请人: Eisai Co., Ltd.
发明人: Okano, Kazuo , Asano, Osamu , Shimomura, Naoyuki , Kawahara, Tetsuya , Abe, Shinya , Miyazawa, Shuhei , Miyamoto, Mitsuaki , Yoshimura, Hiroyuki , Harada, Koukichi , Nagaoka, Junsaku , Kawata, Tsutomu , Yoshimura, Tsutomu , Suzuki, Hiromasa , Souda, Shigeru , Machida, Yoshimasa , Katayama, Kouichi , Yamatsu, Isao
IPC分类号: C07D213/40 , C07D405/12 , C07D401/12 , C07D401/06 , A61K31/44
CPC分类号: C07D213/40 , C07D401/06 , C07D401/12 , C07D405/12 , Y10S514/921
-
公开(公告)号:EP0149847A3
公开(公告)日:1989-11-08
申请号:EP84116353.8
申请日:1984-12-27
申请人: Eisai Co., Ltd.
发明人: Yamatsu, Isao , Suzuki, Takeshi , Abe, Shinya , Nakamoto, Kouji , Kajiwara, Akiharu , Katayama, Kouichi , Tsunoda, Hajime , Murakami, Manabu , Ono, Hideki , Yamada, Kouji
IPC分类号: A61K31/045 , A61K31/66
CPC分类号: A61K31/045 , A61K31/66
摘要: Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.
-
6.A pharmaceutical composition and the use thereof for the treatment of inflammation 失效
标题翻译: 药物组合物及其用于治疗炎症的用途公开(公告)号:EP0107188B1
公开(公告)日:1986-02-26
申请号:EP83110533.3
申请日:1983-10-21
申请人: Eisai Co., Ltd.
发明人: Katoh, Yoshinori , Tajima, Tetsuya , Yamatsu, Isao , Suzuki, Takeshi , Abe, Shinya , Kajihara, Akiharu , Sugitani, Tohru
CPC分类号: A61K31/20 , C07C57/03 , Y10S514/825
-
公开(公告)号:EP0149847A2
公开(公告)日:1985-07-31
申请号:EP84116353.8
申请日:1984-12-27
申请人: Eisai Co., Ltd.
发明人: Yamatsu, Isao , Suzuki, Takeshi , Abe, Shinya , Nakamoto, Kouji , Kajiwara, Akiharu , Katayama, Kouichi , Tsunoda, Hajime , Murakami, Manabu , Ono, Hideki , Yamada, Kouji
IPC分类号: A61K31/045 , A61K31/66
CPC分类号: A61K31/045 , A61K31/66
摘要: Dolichol or phosphate thereof is useful as a therapeutically treating and preventive agent, in particular, for hyperuricuria, hyperlipemia, diabetes and hepatic diseases.
摘要翻译: 多立方醇或其磷酸盐可用作治疗和预防剂,特别是用于尿尿尿,高脂血症,糖尿病和肝脏疾病。
-
8.6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraene-2-ol, a process for producing same and a pharmaceutical composition 失效
标题翻译: 6,10,14,18-四甲基-5,9,13,17-壬二烯-2-醇,其制备方法和药物组合物公开(公告)号:EP0046995B1
公开(公告)日:1983-05-25
申请号:EP81106734.7
申请日:1981-08-28
申请人: Eisai Co., Ltd.
发明人: Yamatsu, Isao , Inai, Yuichi , Abe, Shinya , Suzuki, Takeshi , Ohgou, Toshiharu , Murakami, Manabu , Oketani, Kiyoshi , Fujisaki, Hideaki
IPC分类号: C07C33/02 , C07C29/136 , A61K31/045
CPC分类号: C07C33/02
-
9.Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases 失效
标题翻译: 含有特别是医疗制剂Polyprenylderivate具有抗癌活性,癌症和皮肤病的预防和治疗的治疗组合物。公开(公告)号:EP0059258A1
公开(公告)日:1982-09-08
申请号:EP81109393.9
申请日:1981-10-30
申请人: Eisai Co., Ltd.
发明人: Yamatsu, Isao , Inai, Yuichi , Abe, Shinya , Suzuki, Takeshi , Suzuki, Yoshikazu , Tagaya, Osamu , Suzuki, Kouichi , Abe, Kouichi , Yamada, Kouji
IPC分类号: C07C57/03 , C07C69/533 , C07C69/587 , C07C103/133 , C07C49/203 , A61K31/12 , A61K31/23 , A61K31/16
CPC分类号: A61K31/23 , A61K31/12 , A61K31/16 , C07C49/203 , C07C57/03
摘要: group, or
in which each of n and m is 0, 1 or 2, n + m is 0, 1 or 2,
and B is
or
[in which R represents a hydroxyl group, a lower alkoxy (wherein each of R, and R 2 is a hydrogen atom, a lower alkyl group or an aryl group)]; provided that R is a lower alkoxy or
especially as anti-cancer agent.摘要翻译: 药物组合物,其包含具有下式的聚异戊二烯类化合物:
Ñ -
10.Conjugated polyprenylcarboxylic acids and their derivatives as well as pharmaceutical preparations containing these compounds 失效
标题翻译: 共轭Polyprenylcarbonsäuren和它们的衍生物和含有它们的药物组合物。公开(公告)号:EP0054732A1
公开(公告)日:1982-06-30
申请号:EP81109391.3
申请日:1981-10-30
申请人: Eisai Co., Ltd.
发明人: Yamatsu, Isao , Inai, Yuichi , Abe, Shinya , Suzuki, Takeshi , Suzuki, Yoshikazu , Tagaya, Osamu , Suzuki, Kouichi , Abe, Kouichi , Yamada, Kouji
IPC分类号: C07C57/03 , C07C69/587 , C07C103/133 , A61K31/19 , A61K31/23 , A61K31/16
摘要: A conjugated polyprenylcarboxylic acid and its derivative having the formula:
in which each of n and m is 0, 1 or 2, n+m is 1 or 2, A is
and R is a hydroxyl group, a lower alkoxy group or
wherein each of R, and R 2 represents a hydrogen atom, a lower alkyl group, or an aryl group; provided that R is
n is 1 and m is 0.
There are also descrived pharmaceutical preparations containing above compounds.
-
-
-
-
-
-
-
-
-